Header
 
Login
 

Privatsphäre-Einstellungen

Wir verwenden Cookies auf unserer Website. Einige von ihnen sind unerlässlich, während andere uns helfen, diese Website und Ihre Erfahrungen zu verbessern.

Notwendig Statistik Marketing
Auswahl bestätigen
Weitere Einstellungen

Hier finden Sie eine Übersicht aller verwendeten Cookies. Sie können ganzen Kategorien Ihre Zustimmung geben oder weitere Informationen anzeigen und bestimmte Cookies auswählen.

Alle auswählen
Auswahl bestätigen
Notwendig Cookies
Wesentliche Cookies ermöglichen grundlegende Funktionen und sind für die ordnungsgemäße Funktion der Website erforderlich.
Statistik Cookies
Statistik-Cookies sammeln anonym Informationen. Diese Informationen helfen uns zu verstehen, wie unsere Besucher unsere Website nutzen.
Marketing Cookies
Marketing-Cookies werden von Werbekunden oder Publishern von Drittanbietern verwendet, um personalisierte Anzeigen zu schalten. Sie tun dies, indem sie Besucher über Websites hinweg verfolgen
Zurück
    Prüfung auf Sterilität nach international harmonisierten Vorschriften

    Hanfried Seyfarth

    Abteilung Biopharmazeutische Qualität und Compliance/Mikrobiologie, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach/Riss

    Testing for Sterility According to the International Harmonised Regulations

    The 6th Supplement of Ph.Eur. 4 (Ph.Eur. 4.6) contains the harmonised text of the test for sterility. The new version contains numerous changes compared to the previous section in the Ph.Eur. 4 (2002):

    • Applicability
    Other methods are expressly permitted (important with a view to parametric release). The text is the official method = decision method.

    • Certain of declaration
    For products sterilised in the final container attention is drawn to the possibility of parametric release (in the non harmonised and non mandatory section „Guidelines for using the test for sterility“ The test for sterility must be carried out always in the case of aseptic production.

    • Test conditions
    Description more general. More detailed information are given in the Guidelines for using the test for sterility

    • Controls
    Environmental controls must be done omn a daily basis (they must be available when deciding about necessity of possible repeat tests).
    Negative controls: Daily testing as they must be available when deciding about necessity of possible repeat tests.

    • Duration of incubation
    Generally 14 days.

    • Method validation
    Always for new products and by alteration of test conditions.
    Reference organisms: Same organisms as before. Clarification - all organisms must be used.
    Age of the reference organisms: Max. 5 passages from the original.
    Inoculation of organisms: The procedure is described in great detail.
    Duration of incubation: Is now fixed as 5 days.

    • Individual Forms of application
    Detailed description of the testing of parenteral preparations, eye preparations and other non-injectable preparations.

    • Sampling number
    Unchanged. In USP and JP will be this mandatory, in Ph.Eur. only recommendation. Requirements for bulk are now included.

    • The amount to be tested
    Has in part changed (possibly a complete new validation of the method may be required)

    • Evaluation
    Repeat tests are only permitted under certain conditions.
    Aseptic preparations: Repeat test practically impossible.
    Product sterilises in final container:
    Chance in identification of organism with more sensitive tests, for example, molecular typing with RNA/DNA homology

    • The procedure in the case of turbidity of nutrient media Regulation: 14 days incubation of original test and 3 days incubation of subculture.

    • Nutrient media
    Unchanged.

    • Nutrient media controls
    The possibility of a parametric release are discussed.


    Key words Europäisches Arzneibuch (Ph.Eur. 4.6) • Steriltest, Anwendbarkeit, Durchführung, Methoden, Neufassung, Validierung
     




    © ECV- Editio Cantor Verlag (Germany) 2003

     

    pharmind 2003, Nr. 12, Seite 1263